Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voluven acute hemodilution study in pediatric congenital heart disease
ChiCTR-IPR-15006963Phase 4Recruiting
- Sponsor
- Yantai Mountain Hospital
- Start
- Sep 2015
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of Volulyte in Cardiovascular Malformation (CVM) (2 arms), sponsored by Yantai Mountain Hospital. Primary endpoint: Routine blood test. Started Sep 2015; status: recruiting.
02
Drugs
Volulyte
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on ChiCTR-IPR-15006963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006963.